Canagliflozin for the Treatment of Diabetic Kidney Disease and Implications for Clinical Practice: A Narrative Review
Davida Kruger
Virginia Valentine
10.6084/m9.figshare.12164172.v1
https://adisjournals.figshare.com/articles/figure/Canagliflozin_for_the_Treatment_of_Diabetic_Kidney_Disease_and_Implications_for_Clinical_Practice_A_Narrative_Review/12164172
<p>The above Summary Slide represents the opinions of
the authors. For a full list of declarations, including funding and author
disclosure statements, please see the full text online (see “read the
peer-reviewed publication” opposite).<br></p>
<p>© The authors, CC-BY-NC 2020.<b>
</b></p>
2020-05-05 13:46:30
Canagliflozin
Cardiovascular disease
Diabetic kidney disease
Randomized trials
Sodium glucose co-transporter 2 inhibitor
Type 2 diabetes